Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

Clinical trial NCT05891171 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05891171
Sponsor: Arcus Biosciences, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Advanced Malignancies Bladder Cancer Cervical Cancer Esophageal Cancer Gastric Cancer Gastroesophageal-junction Cancer (GEJ)Head and Neck Squamous Cell Carcinoma (HNSCC)Non-Small Cell Lung Cancer (NSCLC)Ovarian Cancer Renal Cell Carcinoma (RCC)Triple Negative Breast Cancer (TNBC)

Start date: 2023-10-13
Primary completion: 2027-09-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.